Enantiomer Plasma Concentrations of Tranylcypromine as a Test for Peripheral Monoamine Oxidase Inhibition
Authors:
- 24 August 2023
- journal article
- letter
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 45 (5) , 708-710
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Insufficient recovery of monoamine oxidase in a bioequivalence study of the monoamine oxidase inhibitor tranylcypromine: Recommendation of the tranylcypromine enantiomer testInt. Journal of Clinical Pharmacology and Therapeutics, 2022
- Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid MalignanciesClinical Cancer Research, 2021
- Tranylcypromine in mind (Part I): Review of pharmacologyEuropean Neuropsychopharmacology, 2017
- Kinetics of MAO Inhibitors2015
- Rapid Conversion From One Monoamine Oxidase Inhibitor to AnotherThe Journal of Clinical Psychiatry, 1997
- Enantiospecific high-performance liquid chromatographic assay with fluorescence detection for the monoamine oxidase inhibitor tranylcypromine and its applicability in pharmacokinetic studiesJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Plasma TranylcypromineJournal of Clinical Psychopharmacology, 1990
- Effects of tranylcypromine stereoisomers on monamine oxidation in man.1980